验证术后第1天引流液淀粉酶水平预测远端胰腺切除术后临床相关胰瘘:基于NSQIP数据库
本研究利用NSQIP数据库2014至2016年1007例远端胰腺切除术患者,验证术后第1天引流液淀粉酶2000 U/L预测临床相关胰瘘的效能。结果显示该阈值下敏感度67.98%、特异度63.81%,阳性预测值32.17%、阴性预测值88.75%,约登指数0.32,提示该阈值在敏感度与特异度间取得最佳平衡。
要点
- 术后第1天引流液淀粉酶2000 U/L可预测远端胰腺切除术后临床相关胰瘘。
- 该阈值阴性预测值达88.75%,有助于识别低风险患者。
- 该阈值或可用于设计早期拔除引流管的临床试验。
核心结论
- 术后第1天引流液淀粉酶2000 U/L被独立验证为预测远端胰腺切除术后临床相关胰瘘的最佳平衡阈值。
研究设计与样本
- 回顾性验证研究,使用NSQIP胰腺切除特定参与者文件2014至2016年数据。
- 共纳入1007例接受远端胰腺切除术的患者。
主要发现
- 临床相关胰瘘发生于203例患者(20.2%)。
- 第1天引流液淀粉酶均值4290.04±8492.35 U/L。
- 淀粉酶≥2000 U/L组临床相关胰瘘发生率32.5%,<2000 U/L组为11.25%(P<.0001)。
- 淀粉酶≥2000 U/L组引流管拔除前平均天数8.83天 vs 5.59天(P<.0001)。
- 淀粉酶<2000 U/L患者中仍有11%发生临床相关胰瘘,且未发现可预测该并发症的术前特征。
关键数值与推荐
- 以2000 U/L为阈值,敏感度67.98%、特异度63.81%、阳性预测值32.17%、阴性预测值88.75%、约登指数0.32。
临床怎么用
- 术后第1天引流液淀粉酶2000 U/L可用于风险分层,低风险患者或可考虑早期拔管。
- 该阈值可用于设计远端胰腺切除术后早期拔除引流管的临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of postoperative day 1 drain fluid amylase level in predicting clinically relevant postoperative pancreatic fistula is under investigation. In a previous multicenter study conducted on 338 patients undergoing distal pancreatectomy, day 1 drain fluid amylase level has been correlated to the development of a clinically relevant pancreatic fistula and an amylase value of 2,000 U/L was found to be most predictive of the development of clinically relevant postoperative pancreatic fistula. Our objective was to validate the previously established cutoff level for drain fluid amylase on postoperative day 1 after distal pancreatectomy as a predictor for clinically relevant postoperative pancreatic fistula using a different patient population from the National Surgery Quality Improvement Program database. METHODS: We studied all patients undergoing distal pancreatectomy from the National Surgery Quality Improvement Program pancreatectomy specific participant use file from 2014 to 2016. We applied the day 1 drain fluid amylase level of 2,000 U/L cutoff to divide patients into 2 groups and compared clinical outcomes in both groups. Among patients with a day 1 drain fluid amylase level < 2,000 U/L, we compared the patient characteristics of those who developed a clinically relevant postoperative pancreatic fistula to those who did not. Finally, to independently validate the previously defined day 1 drain fluid amylase level, we proceeded to determine the optimal cutoff value of day 1 drain fluid amylase level, which can be used as a predictor for the development of clinically relevant postoperative pancreatic fistula after distal pancreatectomy using a receiving operating characteristic curve. RESULTS: A total of 1,007 patients underwent distal pancreatectomy. The mean day 1 drain fluid amylase level was 4,290.04 ± 8,492.35 U/L. Clinically relevant postoperative pancreatic fistula occurred in 203 patients (20.2%). Using bivariate analysis, patients with day 1 drain fluid amylase level ≥ 2,000 U/L were more likely to develop clinically relevant postoperative pancreatic fistula (32.5% vs 11.25%, P < .0001), to have a higher mean number of days before drain removal (8.83 vs 5.59, P < .0001), to have a drain 30 days postoperatively (12.59% vs 3.63%, P < .0001), and to undergo percutaneous drainage (13.75% vs 9.69%, P = .04). Among patients with a day 1 drain fluid amylase level < 2,000 U/L, 11% of patients went on to develop a clinically relevant postoperative pancreatic fistula. Analysis of this subgroup of patients did not identify any discernable preoperative characteristics that were predictive of this complication. Application of maximal Youden index calculated the day 1 drain fluid amylase level value at 2,000 U/L with a sensitivity of 67.98% and a specificity of 63.81% for clinically relevant postoperative pancreatic fistula, with a positive predictive value of 32.17%, a negative predictive value of 88.75%, and a Youden index of 0.32. CONCLUSION: Using a different population of patients and a different data set as well as an independent analysis, we successfully validated a day 1 drain fluid amylase level of 2,000 U/L as striking the best balance in terms of sensitivity and specificity for the detection of clinically relevant postoperative pancreatic fistula. The identified cutoff might be employed in the design of a trial of early drain removal in patients undergoing distal pancreatectomy.
引用
- Daniel F, Tamim H, Hosni M, et al. Validation of day 1 drain fluid amylase level for prediction of clinically relevant fistula after distal pancreatectomy using the NSQIP database. Surgery. 2018. PMID: 30414706. doi:10.1016/j.surg.2018.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。